Cell Therapy and Its to Sell Therapy

Since we started with covid i think the covi studies have identified a whole slo of disregulated cells. And what is remarkable is that many of them are similar to cells that we see in chronic diseases of the lungs, like idiopathic pulmonary pibroses. We think maybe similar disease processes are taking place on an accelerated time line in covid patients and on a much slower kind of chronic disease time line in pulmonary pibrosis patients. But it could be similar disease mechanisms. And if it is, then you are going after the same targets, which is extremely, could be extremely beneficial to patients one day.